0 147

Cited 0 times in

A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib + rucaparib in patients with metastatic castration-resistant prostate cancer

DC Field Value Language
dc.contributor.author신상준-
dc.date.accessioned2023-06-02T00:38:18Z-
dc.date.available2023-06-02T00:38:18Z-
dc.date.issued2022-02-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194318-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Society of Clinical Oncology-
dc.relation.isPartOfJOURNAL OF CLINICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleA phase Ib, open-label study evaluating the safety and efficacy of ipatasertib + rucaparib in patients with metastatic castration-resistant prostate cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorDavid William Pook-
dc.contributor.googleauthorDaniel M. Geynisman-
dc.contributor.googleauthorJoan Carles-
dc.contributor.googleauthorFilippo G. De Braud-
dc.contributor.googleauthorAnthony M. Joshua-
dc.contributor.googleauthorJose Luis Perez-Gracia-
dc.contributor.googleauthorCasilda Llácer Pérez-
dc.contributor.googleauthorSang Joon Shin-
dc.contributor.googleauthorBruno Fang-
dc.contributor.googleauthorMinal A. Barve-
dc.contributor.googleauthorMarco Maruzzo-
dc.contributor.googleauthorSergio Bracarda-
dc.contributor.googleauthorMiso Kim-
dc.contributor.googleauthorYannick Kerloeguen-
dc.contributor.googleauthorJorge Daniel Gallo-
dc.contributor.googleauthorSophia Maund-
dc.contributor.googleauthorAdam Harris-
dc.contributor.googleauthorKuan-Chieh Huang-
dc.contributor.googleauthorDhruvitkumar S. Sutaria-
dc.contributor.googleauthorHoward Gurney-
dc.identifier.doi10.1200/JCO.2022.40.6_suppl.095-
dc.contributor.localIdA02105-
dc.relation.journalcodeJ01331-
dc.identifier.eissn1527-7755-
dc.identifier.urlhttps://ascopubs.org/doi/10.1200/JCO.2022.40.6_suppl.095-
dc.contributor.alternativeNameShin, Sang Joon-
dc.contributor.affiliatedAuthor신상준-
dc.citation.volume40-
dc.citation.number6-
dc.citation.startPageS95-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, Vol.40(6) : S95, 2022-02-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.